help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 22, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1732
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/5/2882    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRAMBACH, T.
Right arrow Articles by DIETL, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRAMBACH, T.
Right arrow Articles by DIETL, J.

Submitted on August 31, 2004
Accepted on February 16, 2005

Self-limitation of intravenous tocolysis with {beta}2-adrenergic agonists is mediated through receptor G protein uncoupling

TORSTEN FRAMBACH*, THOMAS MÜLLER, SEBASTIAN FREUND, STEFAN ENGELHARDT, MARC SÜTTERLIN, MARTIN J. LOHSE, and JOHANNES DIETL

Department of Obstetrics and Gynecology (T.F., T.M., M.S., J.D.) Department of Pharmacology and Toxicology (S.F., M.J.L.) and Rudolf-Virchow-Center, DFG Research Center for Experimental Biomedicine (S.E.), Bayerische Julius-Maximilians-Universität Würzburg, Germany

* To whom correspondence should be addressed. E-mail: frambach t{at}klinik.uni-wuerzburg.de.

Tocolysis with a {beta}-adrenergic receptor agonist is the most common approach to premature labor management after the 25th week of pregnancy. However, prolonged treatment is associated with a marked loss of efficacy. The biochemical mechanisms involved remain unclear. This study was undertaken to investigate the effect of fenoterol on {beta}-adrenergic receptor signal transduction in human myometrium. Myometrial biopsy specimens were obtained from 40 women at cesarean section between the 25th and 34th week of pregnancy. Nineteen patients had received no tocolysis (controls, group I) and 21 had been treated with fenoterol (< 48 h in 10, group II; ≥ 48 h in 11, group III). As methods we used membrane preparation, Adenylyl cyclase assay and cAMP Radio Immuno Assay. Adenylyl cyclase activity was determined by the measurement of cAMP levels to evaluate signal transduction after stimulation of {beta}-adrenergic receptors with isoproterenol, G protein with GTP, and adenylyl cyclase with forskolin. The functional activity of GTP-binding regulatory proteins (Gs) and adenylyl cyclase was not altered by fenoterol treatment. In the control group, the increase in adenylyl cyclase activity in response to GTP plus isoproterenol was greater than in response to GTP alone. The increase was reduced by 50% in group II and was insignificant in group III. There was no correlation between gestational age and basal adenylyl cyclase activity. Intravenous tocolysis with the {beta}2-adrenergic receptor agonist fenoterol leads to complete desensitization of the {beta}-adrenergic receptor system. In addition to the known reduction in receptor number (down-regulation) as underlying mechanism, uncoupling of the receptor from the stimulatory G protein Gs was identified.


Key words: premature labor • {beta}-adrenergic receptor agonist • tocolysis • human myometrium • G-Protein




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
T. M. Reinheimer, G. J. Chellman, J. C. Resendez, J. K. Meyer, and W. H. Bee
Barusiban, An Effective Long-Term Treatment of Oxytocin-Induced Preterm Labor in Nonhuman Primates
Biol Reprod, November 1, 2006; 75(5): 809 - 814.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society